ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL FORMULATION DEVELOPMENT
Artificial Intelligence (AI) is emerging as a transformative technology in pharmaceutical formulation development by improving the efficiency, accuracy, and speed of drug development processes. Traditional formulation development involves time-consuming experiments, extensive laboratory investigations, and trial-and-error approaches to identify suitable ingredients and optimize formulation parameters. AI-based techniques, including machine learning, deep learning, artificial neural networks, and predictive modelling, offer innovative solutions to overcome these challenges. These technologies can analyze large datasets, predict drug–excipient interactions, optimize formulation compositions, and evaluate critical quality attributes of pharmaceutical products. AI also plays an important role in selecting appropriate excipients, predicting drug solubility, dissolution profiles, stability, and bioavailability, thereby supporting the development of safe, effective, and high-quality drug formulations. Furthermore, the integration of AI with Quality by Design (QbD), process analytical technology (PAT), and continuous manufacturing can enhance process optimization and reduce development costs. AI-driven approaches have potential applications in the development of tablets, capsules, nanoparticles, liposomes, controlled-release systems, and other advanced drug delivery systems. Despite its significant advantages, challenges such as data quality, model validation, regulatory acceptance, and implementation costs need to be addressed. Overall, artificial intelligence represents a promising approach to modernizing pharmaceutical formulation development by enabling faster decision-making, reducing experimental workload, and supporting the development of innovative and personalized drug delivery systems. Keywords: Artificial Intelligence, Pharmaceutical Formulation, Machine Learning, Deep Learning, Drug Delivery Systems, Quality by Design, Formulation Optimization.
Authors
- Sk. Afrin V.Vasu Naik*
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24316931
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00